Jump to content

COAT platelet defect: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
COAT platelet defect: Removed unnecessary heading
Added tags to the page using Page Curation (uncategorised, one source)
Line 1: Line 1:
{{one source|date=January 2022}}

A '''collagen- and thrombin-activated''' (COAT) platelet defect is a [[platelet function disorder]] that is due to a reduced ability to generate [[procoagulant platelets]]. It is associated with a clinically relevant bleeding phenotype.
A '''collagen- and thrombin-activated''' (COAT) platelet defect is a [[platelet function disorder]] that is due to a reduced ability to generate [[procoagulant platelets]]. It is associated with a clinically relevant bleeding phenotype.


Line 5: Line 7:
==References==
==References==
{{Reflist}}
{{Reflist}}

{{uncategorised|date=January 2022}}

Revision as of 15:44, 16 January 2022

A collagen- and thrombin-activated (COAT) platelet defect is a platelet function disorder that is due to a reduced ability to generate procoagulant platelets. It is associated with a clinically relevant bleeding phenotype.

During physiological platelet activation, a fraction of platelets expresses phosphatidylserine on their surface and become highly efficient in sustaining thrombin generation. These so-called COAT platelets, can be generated by dual-agonist stimulation with collagen and thrombin in a laboratory setting. COAT platelet defects should be distinguished from Scott syndrome, a rare bleeding disorder in which patients have impaired phospholipid scrambling and do not express negatively charged phospholipids on their surface even after treatment with calcium ionophores.[1]

References

  1. ^ Aliotta, A; Alberio, L (Feb 24, 2021). "Thrombocytopathies: Not Just Aggregation Defects - The clinical relevance of Procoagulant Platelets". J Clin Med. 10 (5): 1–28. PMID 33668091.